1. Vertex Pharmaceuticals Incorporated (VRTX): Value Stock To Outperform Growth  The RNS Daily
2. Long-Term Outlook For Vertex  Seeking Alpha
3. Vertex Pharmaceuticals’ (NASDAQ:VRTX) “Buy” Rating Reiterated at Cantor Fitzgerald  Fairfield Current
4. Vertex Pharmaceuticals Incorporated (VRTX): This May Not Have Been Coincidental  Post Analyst
5. Analyst Earnings Estimates Screen: Vertex Pharmaceuticals Incorporated (VRTX)  Analyst Journal
6. View full coverage on Google News

Maverix Metals signs silver stream agreement for Northern Vertex’s Moss mine  Compelo

Maverix Metals has executed a definitive agreement, which increases the scope of the previously announced acquisition of a silver stream from a wholly-owned ...

Vertex Hits Again in CF as First Three-Drug Combo Succeeds in Phase 3  Xconomy

Vertex Pharmaceuticals already dominates the landscape of treatments for cystic fibrosis, and its position got even better today. Vertex (NASDAQ: ]) said.

Will Vertex finally reach a deal with the UK over its cystic fibrosis drug? - STAT  STAT

The drug maker late last week met with two government agencies to hash out long-standing differences over its Orkambi medicine.

Vertex Pharma's triplet therapy for CF successful in two late-stage studies  Seeking Alpha

Vertex Pharmaceuticals (VRTX) announces the successful outcome of two Phase 3 clinical trials evaluating the triple combination of VX-659, a next-generatio.

Vertex Looks to Capture the Rest of Its Multibillion-Dollar Market  The Motley Fool

Vertex Pharmaceuticals (NASDAQ:VRTX) is on pace to hit its 2018 goal of about $3 billion in sales from its three cystic fibrosis drugs, but the biotech only has a ...

Vertex Achieves Oracle Validated Integration of Indirect Tax O Series with JD Edwards EnterpriseOne  CPAPracticeAdvisor.com

Vertex Inc., a provider of tax technology and services and Platinum level member of Oracle PartnerNetwork (OPN), has achieved Oracle Validated Integration of ...

Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals  The Motley Fool

Ascending and descending? That might be how some investors view Vertex Pharmaceuticals (NASDAQ:VRTX) and Regeneron Pharmaceuticals ...

Vertex Pharmaceuticals Incorporated (VRTX) Touting an ERP5 Score of 4763  Hawthorn Caller

Vertex Pharmaceuticals Incorporated (VRTX) of the Healthcare sector has an ERP5 rank of 4763. The ERP5 Rank is an investment tool that analysts use to.

DekaBank Deutsche Girozentrale Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)  Fairfield Current

DekaBank Deutsche Girozentrale lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 22.4% in the third quarter, according to its ...

Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) to Treat Patients with Cystic Fibrosis Aged 12 to <24 months with Certain Mutations in the CFTR Gene  Business Wire

Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for KALYDECO® (ivacaf.

Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids  Zacks.com

CHMP gives positive opinion to Vertex's (VRTX) label expansion of Orkambi.

Cowen Analyst Goes All in For Vertex (VRTX) Stock  Smarter Analyst

Vertex (VRTX) is Cowen analyst's top large-cap pick for the second year in a row. That's how Phil Nadeau put it while increasing his price target from $200 to ...

Maverix strikes silver stream deal with Northern Vertex  www.mining-journal.com

In return for the up-front capital the silver stream entitles Maverix to buy all the silver production from the Moss mine, which is operated by Northern Vertex ...

UK calls Vertex on contentious Orkambi negotiations  BioPharma Dive

The U.K.'s National Health Services (NHS) and Vertex Pharmaceuticals are still sparring over the price of Orkambi for the treatment of cystic fibrosis. The latest ...